Alerts will be sent to your verified email
Verify Email
INNOVATIVE
|
Innovative Ideals
|
Mono Pharmacare
|
Davin Sons Retail
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.91 % | 7.94 % | 22.93 % |
|
5yr average Equity Multiplier
|
4.57 | 3.7 | 2.0 |
|
5yr Average Asset Turnover Ratio
|
0.11 | 1.16 | 0.77 |
|
5yr Avg Net Profit Margin
|
-311.17 % | 2.14 % | 9.83 % |
|
Price to Book
|
0.0 | 0.0 | 0.0 |
|
P/E
|
21.93 | 7.06 | 13.12 |
|
5yr Avg Cash Conversion Cycle
|
286.06 Days | 151.42 Days | 139.64 Days |
|
Inventory Days
|
2703.15 Days | 219.92 Days | 60.96 Days |
|
Days Receivable
|
275.67 Days | 79.66 Days | 124.65 Days |
|
Days Payable
|
263.73 Days | 54.73 Days | 65.05 Days |
|
5yr Average Interest Coverage Ratio
|
-32.84 | 2.12 | 242.91 |
|
5yr Avg ROCE
|
-24.66 % | 11.4 % | 21.53 % |
|
5yr Avg Operating Profit Margin
|
-375.49 % | 5.11 % | 13.51 % |
|
5 yr average Debt to Equity
|
3.8 | 2.07 | 0.32 |
|
5yr CAGR Net Profit
|
n/a | 34.58 % | n/a |
|
5yr Average Return on Assets
|
-13.6 % | 2.31 % | 9.89 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
16.05 % | 56.72 % | 63.18 % |
|
Share Pledged by Promoters
|
94.49 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-36.42 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Innovative Ideals
|
Mono Pharmacare
|
Davin Sons Retail
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|